Chenming Zeng

665 total citations
22 papers, 440 citations indexed

About

Chenming Zeng is a scholar working on Molecular Biology, Cell Biology and Plant Science. According to data from OpenAlex, Chenming Zeng has authored 22 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Cell Biology and 5 papers in Plant Science. Recurrent topics in Chenming Zeng's work include Aldose Reductase and Taurine (5 papers), CRISPR and Genetic Engineering (5 papers) and Genetics, Aging, and Longevity in Model Organisms (4 papers). Chenming Zeng is often cited by papers focused on Aldose Reductase and Taurine (5 papers), CRISPR and Genetic Engineering (5 papers) and Genetics, Aging, and Longevity in Model Organisms (4 papers). Chenming Zeng collaborates with scholars based in China, United Kingdom and Macao. Chenming Zeng's co-authors include Bo Yang, Qiaojun He, Hong Zhu, Ji Cao, Meidan Ying, Linlin Chang, Chenxi Zhao, Xiaoyang Dai, Fangjie Yan and Tao Yuan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

Chenming Zeng

22 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chenming Zeng China 12 304 128 77 60 50 22 440
Yannasittha Jiramongkol United Kingdom 8 261 0.9× 42 0.3× 99 1.3× 59 1.0× 13 0.3× 12 373
Atsushi Hatanaka Japan 10 360 1.2× 60 0.5× 83 1.1× 69 1.1× 27 0.5× 13 429
Müge Öğrünç United States 6 280 0.9× 36 0.3× 75 1.0× 62 1.0× 16 0.3× 6 387
Helena Silva Cascales Sweden 8 241 0.8× 103 0.8× 45 0.6× 77 1.3× 11 0.2× 9 380
Elizabeth G. Hunt United States 7 236 0.8× 36 0.3× 81 1.1× 31 0.5× 40 0.8× 8 338
Kyle Vaughn Laster China 13 296 1.0× 53 0.4× 83 1.1× 80 1.3× 17 0.3× 34 447
Brian Frederick United States 8 321 1.1× 121 0.9× 65 0.8× 26 0.4× 22 0.4× 10 474
Derek J. Hoelz United States 9 278 0.9× 45 0.4× 60 0.8× 93 1.6× 16 0.3× 15 387
Xiangzi Han United States 14 361 1.2× 91 0.7× 71 0.9× 100 1.7× 28 0.6× 15 436

Countries citing papers authored by Chenming Zeng

Since Specialization
Citations

This map shows the geographic impact of Chenming Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenming Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenming Zeng more than expected).

Fields of papers citing papers by Chenming Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenming Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenming Zeng. The network helps show where Chenming Zeng may publish in the future.

Co-authorship network of co-authors of Chenming Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Chenming Zeng. A scholar is included among the top collaborators of Chenming Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenming Zeng. Chenming Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zeng, Chenming & Eric A. Miska. (2025). New insights into how parental worms protect their offspring. Cell Research. 35(8). 545–546. 1 indexed citations
2.
Yuan, Tao, Yue Liu, Meijia Qian, et al.. (2025). Josephin Domain Containing 2 (JOSD2) inhibition as Pan-KRAS-mutation-targeting strategy for colorectal cancer. Nature Communications. 16(1). 3623–3623. 2 indexed citations
3.
Zhou, Xiaotian, Chenming Zeng, Ting Xu, et al.. (2024). Nucleolar stress induces nucleolar stress body formation via the NOSR-1/NUMR-1 axis in Caenorhabditis elegans. Nature Communications. 15(1). 7256–7256. 1 indexed citations
4.
Chen, Xiangyang, Ke Wang, Chengming Zhu, et al.. (2024). Germ granule compartments coordinate specialized small RNA production. Nature Communications. 15(1). 5799–5799. 15 indexed citations
5.
Yuan, Tao, Chenming Zeng, Jiawei Liu, et al.. (2024). Josephin domain containing 2 (JOSD2) promotes lung cancer by inhibiting LKB1 (Liver kinase B1) activity. Signal Transduction and Targeted Therapy. 9(1). 11–11. 9 indexed citations
6.
Liu, Xiangning, Chenming Zeng, Meijia Qian, et al.. (2024). Ivacaftor, a CFTR potentiator, synergizes with osimertinib against acquired resistance to osimertinib in NSCLC by regulating CFTR-PTEN-AKT axis. Acta Pharmacologica Sinica. 46(4). 1045–1057. 2 indexed citations
7.
Zeng, Chenming, Xiangning Liu, Liu Yang, et al.. (2023). Cancer-associated fibroblasts drive early pancreatic cancer cell invasion via the SOX4/MMP11 signalling axis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(1). 166852–166852. 7 indexed citations
8.
Zeng, Chenming, Shanhui Liao, Zhongliang Zhu, et al.. (2021). Molecular basis for PICS-mediated piRNA biogenesis and cell division. Nature Communications. 12(1). 5595–5595. 8 indexed citations
9.
Chang, Linlin, Chenxi Zhao, Chenming Zeng, et al.. (2021). AKR1C1 connects autophagy and oxidative stress by interacting with SQSTM1 in a catalytic-independent manner. Acta Pharmacologica Sinica. 43(3). 703–711. 11 indexed citations
10.
Zhu, Hong, Yan Hu, Chenming Zeng, et al.. (2020). The SIRT2-mediated deacetylation of AKR1C1 is required for suppressing its pro-metastasis function in Non-Small Cell Lung Cancer. Theranostics. 10(5). 2188–2200. 16 indexed citations
11.
Zeng, Chenming, Chenxi Zhao, Yuekang Li, et al.. (2020). Machado-Joseph Deubiquitinases: From Cellular Functions to Potential Therapy Targets. Frontiers in Pharmacology. 11. 1311–1311. 24 indexed citations
12.
Zhao, Chenxi, Chenming Zeng, Ke Wang, et al.. (2020). Ubiquitin–proteasome system-targeted therapy for uveal melanoma: what is the evidence?. Acta Pharmacologica Sinica. 42(2). 179–188. 15 indexed citations
13.
Zeng, Chenming, Chenchun Weng, Yonghong Yan, et al.. (2019). Functional Proteomics Identifies a PICS Complex Required for piRNA Maturation and Chromosome Segregation. Cell Reports. 27(12). 3561–3572.e3. 24 indexed citations
14.
Zeng, Chenming, Difeng Zhu, Jun You, et al.. (2019). Liquiritin, as a Natural Inhibitor of AKR1C1, Could Interfere With the Progesterone Metabolism. Frontiers in Physiology. 10. 833–833. 13 indexed citations
15.
Zhao, Chenxi, Chenming Zeng, Song Ye, et al.. (2019). Yes-associated protein (YAP) and transcriptional coactivator with a PDZ-binding motif (TAZ): a nexus between hypoxia and cancer. Acta Pharmaceutica Sinica B. 10(6). 947–960. 36 indexed citations
16.
Zhu, Hong, Dandan Wang, Tao Yuan, et al.. (2018). Multikinase Inhibitor CT-707 Targets Liver Cancer by Interrupting the Hypoxia-Activated IGF-1R–YAP Axis. Cancer Research. 78(14). 3995–4006. 34 indexed citations
17.
Weng, Chenchun, Joanna Kosałka-Węgiel, Przemysław Stempor, et al.. (2018). The USTC co-opts an ancient machinery to drive piRNA transcription in C. elegans. Genes & Development. 33(1-2). 90–102. 31 indexed citations
18.
Yan, Fangjie, et al.. (2018). A novel natural compound Shikonin inhibits YAP function by activating AMPK. 1(3). 136–142. 1 indexed citations
19.
Zeng, Chenming, Linlin Chang, Meidan Ying, et al.. (2017). Aldo–Keto Reductase AKR1C1–AKR1C4: Functions, Regulation, and Intervention for Anti-cancer Therapy. Frontiers in Pharmacology. 8. 119–119. 103 indexed citations
20.
Zhu, Hong, Linlin Chang, Fangjie Yan, et al.. (2017). AKR1C1 Activates STAT3 to Promote the Metastasis of Non-Small Cell Lung Cancer. Theranostics. 8(3). 676–692. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yannasittha Jiramongkol Breakdown of academic impact, for papers by Atsushi Hatanaka Breakdown of academic impact, for papers by Müge Öğrünç Breakdown of academic impact, for papers by Helena Silva Cascales Breakdown of academic impact, for papers by Elizabeth G. Hunt Breakdown of academic impact, for papers by Kyle Vaughn Laster Breakdown of academic impact, for papers by Brian Frederick Breakdown of academic impact, for papers by Derek J. Hoelz Breakdown of academic impact, for papers by Xiangzi Han
Rankless by CCL
2026